MAPT and Alzheimer disease: In the current study, we demonstrate that a panel of scFvs that selectively bind AD-related protein variants of Aβ, tau, and TDP-43 is a very effective tool to identify novel pre-symptomatic blood-based biomarkers of AD and that there is a sex bias in these blood-based protein variant biomarkers.